跳至主要内容
临床试验/TCTR20141017001
TCTR20141017001已完成未知

Safety of Phenylephrine in Antihypotensive Treatment during Spinal Anesthesia for Cesarean Section

Graduate school Chulalongkorn university0 个研究点目标入组 610 人开始时间: 2014年10月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
610

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
Female

入选标准

  • -Age greater than or equal 18 years old.
  • -Singleton baby.
  • -Gestational age greater than or equal to 37 weeks

排除标准

  • Chronic hypertension, gestational hypertension or preeclampsia.
  • - Cardiovascular disease (ischemic heart disease, valvular heart disease, cardiac defect) or cerebrovascular disease (stroke, cerebral aneurysm, cerebral arteriovenous malformation)
  • - Complicated obstetrics (abruptio placenta, placenta previa)
  • - Known fetal abnormalities (intrauterine growth retardation(IUGR), fetal cardiac disease)
  • - History use of monoamine oxidase inhibitor(MAOI).
  • - History use of other drugs that prolonged heart conduction(PR or QT interval)
  • - Contraindications to spinal anesthesia (coagulopathy, intracranial space occupying lesion or patient refusal)

研究者

发起方
Graduate school Chulalongkorn university

相似试验